Stock Events

ALPS Medical Breakthroughs 

$32.96
8
+$0+0% Monday 15:33

Statistics

Day High
0
Day Low
0
52W High
33.51
52W Low
0
Volume
3,080
Avg. Volume
82
Mkt Cap
-
P/E Ratio
-
Dividend Yield
0.22%
Dividend
0.07

Upcoming

Dividends

0.22%Dividend Yield
10Y Growth
N/A
5Y Growth
35%
3Y Growth
N/A
1Y Growth
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0H6M.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
iShares Biotechnology
IBB
Mkt Cap7.41B
iShares Nasdaq Biotechnology ETF, competes as it also invests in biotechnology and pharmaceutical companies, offering a similar focus on the sector.
SPDR Biotech
XBI
Mkt Cap7.19B
SPDR S&P Biotech ETF, directly competes by investing in biotechnology companies, with a broad exposure to the industry.
VanEck Biotech
BBH
Mkt Cap433.07M
VanEck Vectors Biotech ETF, competes by focusing on biotech firms, similar to SBIO's investment strategy.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap1.12B
First Trust NYSE Arca Biotechnology Index Fund, offers competition by targeting biotech firms, providing an alternative in the sector.
Invesco Biotechnology & Genome
PBE
Mkt Cap257.31M
Invesco Dynamic Biotechnology & Genome ETF, competes by investing in biotech and genome companies, offering a similar thematic investment.
Virtus LifeSci Biotech Products
BBP
Mkt Cap20.68M
Virtus LifeSci Biotech Products ETF, competes by focusing on biotech product companies, closely aligning with SBIO's investment focus.
Principal Healthcare Innovators
BTEC
Mkt Cap16.4M
Principal Healthcare Innovators Index ETF, offers competition by investing in healthcare innovation, including biotech, providing a similar growth focus.
ARK Genomic Revolution
ARKG
Mkt Cap1.28B
ARK Genomic Revolution ETF, competes by focusing on genomics and biotech, offering innovative healthcare investment opportunities.
Global X Genomics & Biotechnology
GNOM
Mkt Cap95.21M
Global X Genomics & Biotechnology ETF, competes by investing in companies involved in genomics and biotech, similar to SBIO's focus.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap135.25M
iShares Genomics Immunology and Healthcare ETF, competes by focusing on genomics, immunology, and healthcare, offering a similar investment theme.

About

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Show more...
CEO
Country
US
ISIN
US00162Q5936

Listings